Compare Equinor ASA (EQNR) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinor ASA vs Tempus AI — how do they compare? Equinor ASA trades at $40.98 (market cap $95.91B), while Tempus AI trades at $55.45 (market cap $9.93B). The key difference: Equinor ASA is far larger — about 9.7× Tempus AI's market cap, and Equinor ASA pays a 3.81% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| EQNR | TEM | |
|---|---|---|
Market Cap | $95.91B | $9.93B |
Sector | Energy | Broad Market / Factor |
52-Week High | $42.40 | $103.25 |
52-Week Low | $22.41 | $41.55 |
Enterprise Value | $104.60B | $10.56B |
Dividend Yield | 3.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinor (EQNR) trades at $38.92, down 1.37% over the past day, with a bullish technical signal from moving averages and neutral oscillators. The stock shows strong profitability with a 21.32% ROE and attractive valuation metrics, including a P/E of 10.55 and EV/EBITDA of 2.19. Recent Q2 2026 earnings missed estimates, but revenue grew 40% year-over-year, supported by higher energy prices and production. The company continues shareholder returns via dividends and a share buy-back program.
EQNR presents a mixed outlook: robust cash flow and strategic investments in subsea projects support growth, but declining net income margins and geopolitical energy market volatility pose risks. Analyst consensus is cautious with 30.43% buy ratings, reflecting fair valuation concerns after recent gains. The stock offers value through dividends and buybacks, yet investors face exposure to oil price swings and execution risks in capital projects.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
